"It raises the prospect of a 'one-size-fits-all' cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population." T-cells have ...

These sort of "living drugs"—T-cells modified to expand, recognize and attack cancer cells within the body—offer ... For children with acute lymphoblastic leukemia (ALL), measurable residual ...

"We found ASXL1 mutated in the T cells of all of those patients and decided to investigate further." "We showed Asxl1 disruption endows T cells with superior long-term therapeutic potential ...

I’ve tested smartphones and cell phone plans from all the major carriers—the historic foursome of AT&T, Sprint, T-Mobile, and Verizon, plus Nextel before then—for the Washington Post ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

One such option is an investment in pipeline operator Energy Transfer (NYSE ... by more than $370 million per year once all the projects are fully ramped up.

T-Mobile offers features beyond cell phone plan service built into its ... Both T-Mobile Magenta plans and all three T-Mobile Go5G plans are available, and they’re largely identical to the ...

In the fight against antibiotic resistance, a new technology developed at Chalmers University of Technology, in Sweden, can be of great importance when, for example, hip and knee implants are ...

In people with ALL, something goes wrong with a type of blood stem cell called a lymphoblast. Instead of maturing into fully functioning lymphocytes — important immune-system cells — the lymphoblasts ...

T-Mobile is the third of the three biggest U.S. wireless carriers, after merging with Sprint in 2020. While it has all the standard functionality of the other business cell service providers ...